Hervolution receives 2.5M EUR in funding through the European Innovation Council Accelerator

15 Oct 2021
By Hervolution

We are beyond proud to announce that Hervolution is one of just 65 European companies to receive funding through the European Innovation Council Accelerator. Being selected among more than 4000 applicants, the funding of €2.5m

Related news

News

CEO at SIRION, Christian Thirion, joins Hervolution as a Board Member

02 Mar 2020

By Hervolution

News

New Research Reveals the Crucial Role of Endogenous Retrovirus Immunity in Tumor Immunity and Vaccine Development

09 Jun 2023

By Hervolution

News

Postdoctoral grant allows Hervolution to engage in new exciting collaborations

30 Oct 2020

By Hervolution

Funding

Hervolution has been awarded an EU grant to further explore the role of IPT001 in oncological immunotherapy approaches against hard to treat cancers

16 Dec 2022

By Hervolution